Corcept Therapeutics INC (CORT) — 10-Q Filings

10-Q Filings (6)

• Corcept's Profit Plunges 58% Despite Revenue Growth — Nov 4, 2025 Risk: high
  CORCEPT THERAPEUTICS INC (CORT) reported a significant decrease in net income for the three months ended September 30, 2025, falling to $19.668 million from $47
• Corcept Thrives on Strong Q2 Revenue, Net Income Growth — Jul 31, 2025 Risk: medium
  CORCEPT THERAPEUTICS INC reported total revenues of $123.4 million for the three months ended June 30, 2025, a significant increase from $105.1 million for the
• Corcept Therapeutics Files Q1 2025 10-Q — May 5, 2025 Risk: medium
  Corcept Therapeutics Inc. filed its 10-Q for the period ending March 31, 2025. The filing details the company's financial performance and position. Key financia
• Corcept Therapeutics Files Q3 2024 10-Q — Oct 30, 2024 Risk: medium
  Corcept Therapeutics Inc. filed its 10-Q for the period ending September 30, 2024. The company reported financial results for the third quarter of 2024, detaili
• Corcept Therapeutics Files Q2 2024 10-Q — Jul 29, 2024 Risk: medium
  Corcept Therapeutics Inc. filed its 10-Q for the period ending June 30, 2024. The filing details the company's financial performance and operations for the seco
• Corcept Therapeutics Inc. Files 10-Q for Period Ending March 31, 2024 — May 1, 2024 Risk: low
  CORCEPT THERAPEUTICS INC (CORT) filed a Quarterly Report (10-Q) with the SEC on May 1, 2024. Corcept Therapeutics Inc. filed a 10-Q report for the period ending

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX